Purification and characterization of Protein C activator from Agkistrodon acutus Venom

References

• Yi, Z. Research Progress of Protein C and Protein S Anticogulant SyStem in Plasma. Shanghai J Biomed. Eng. 2002, 23, 34–41.DOI: CNKI:SUN:SHYC.0.2002-01-011.
   Google Scholar
• Ludeman, M. J.; Kataoka, H.; Srinivasan, Y. PAR1 Cleavage and Signaling in Response to Activated Protein C and Thrombin. J. Bio Chem. 2005, 280, 13122–13128. DOI: 10.1074/jbc.M410381200.
   Google Scholar
• Gleeson, E. M.; O'Donnell, J. S.; Preston, R. J. S. The Endothelial Cell Protein C Receptor: Cell Surface Conductor Of Cytoprotective Coagulation Factor Signaling. Cell. Mol. Life Sci. 2012, 69, 717–726. DOI: 10.1007/s00018-011-0825-0.
   PubMed Web of Science ®Google Scholar
• Ebina, Y.; Leko, M.; Naito, S., et al. Low Levels of Plasma Protein S, Protein C and Coagulation Factor XII During Early Pregnancy and Adverse Pregnancy Outcome. Thromb Haemost. 2015, 114, 65–69. DOI: 10.1160/TH14-11-0928.
   Google Scholar
• Zhang, Z. The Efficacy of Activated Protein C for the Treatment of Sepsis: Incorporating Observational Evidence with a Bayesian Approach. BMJ open. 2015, 5, e006524. DOI: 10.1136/bmjopen-2014-006524.
   Google Scholar
• Mosnier, L. O. Activated Protein C in Neuroprotection and Malaria. Curr. Opin. Hematol. 2019, 26, 320–330. DOI: 10.1097/MOH.0000000000000528.
   PubMed Web of Science ®Google Scholar
• Moore, G. W.; Van Cott, E. M.; Cutler, J. A.; Mitchell, M. J.; Adcock, D. M. Recommendations for Clinical Laboratory Testing of Activated Protein C Resistance; Communication from the SSC of the ISTH. J. Thromb. Haemost. 2019, 17, 1555–1561. DOI: 10.1111/jth.14532.
   PubMed Web of Science ®Google Scholar
• Kaier, T. E.; Stengaard, C.; Marjot, J.; Sørensen, J. T.; Alaour, B.; Stavropoulou-Tatla, S.; Terkelsen, C. J.; Williams, L.; Thygesen, K.; Weber, E.; et al. Cardiac Myosin-Binding Protein C to Diagnose Acute Myocardial Infarction in the Pre-Hospital Setting. J. Am. Heart Assoc. 2019, 8, e013152. DOI: 10.1161/JAHA.119.013152.
   PubMed Web of Science ®Google Scholar
• Drummond, S.; Gotskie, G.; Landi, D.; Lindberg, J.; Ross, K.; Siak, S.; Reslink, M.; Chubeck, C.; Brown, R.; Agostino, L.; et al. Partial Thromboplastin Time: Accurate Measurement Through Evidence-Based Practice. Clin. J. Oncol. Nurs. 2019, 23, 431–433. DOI: 10.1188/19.CJON.431-433.
   PubMed Web of Science ®Google Scholar
• Ming-chao, Z.; Ya, Z.; Li, S., et al. Study on Common Influencing Factors for Detecting PT and APTT. J Clin Exp Med. 2015, 14, 1653–1655. DOI: CNKI:SUN:SYLC.0.2015-19-032.
   Google Scholar
• Murakami, M. T.; Arni, R. K. Thrombomodulin-Independent Activation of Protein C and Specificity Of Hemostatically Active Snake Venom Serine Proteinases: Crystal Structures of Native and Inhibited Agkistrodon Contortrix Protein C Activator. J. Biol. Chem. 2005, 280, 39309–39315. DOI: 10.1074/jbc.M508502200.
   PubMed Web of Science ®Google Scholar
• Platonova, T. N.; Gornitskaia, O. V. Isolation and characteristics of the protein C activator from Agkistrodon halys halys snake venom. Ukr Biokhim Zh (1999) 2004, 76, 62–67.
   PubMedGoogle Scholar
• Ramzan, F.; Asmat, A. Venom Protein C Activators as Diagnostic Agents for Defects of Protein C System. Protein Pept. Lett. 2018, 25, 643–651. DOI: 10.2174/0929866525666180619101218.
   PubMed Web of Science ®Google Scholar
• Johnstone, I. B.; Martin, C. A. Comparative Effects Of The Human Protein C Activator, Protac, on the Activated Partial Thromboplastin Clotting Times Of Plasmas, With Special Reference to the Dog. Can. J. Vet. Res. 2000, 64, 117–122. DOI: 10.1080/03079450094180.
   PubMed Web of Science ®Google Scholar
• Román-Domínguez, L.; Neri-Castro, E.; López, H. V.; et al. Biochemical and Immunochemical Characterization of Venoms from Snakes of the Genus Agkistrodon. Toxicon: X. 2019, 1–13. DOI: 10.1016/j.toxcx.2019.100013
   Google Scholar
• Gen-Bao, Z.; Yi, Z.; Yan, K., et al. Purification and Activity Analysis of Protein C Activator from the Agkistrodon Acutus Venom. J Snake. 2008, 20, 249–251. DOI: CNKI:SUN:SZZZ.0.2008-04-002.
   Google Scholar
• Tripodi, A.; Legnani, C.; Lemma, L.; Cosmi, B.; Palareti, G.; Chantarangkul, V.; Mannucci, P. M. Abnormal Protac-Induced Coagulation Inhibition Chromogenic Assay Results are Associated with an Increased Risk of Recurrent Venous Thromboembolism. J. Thromb. Thrombolysis. 2010, 30, 215–219. DOI: 10.1007/s11239-010-0479-z.
   PubMed Web of Science ®Google Scholar
• Li-qiang, H.; Lu-ning, Z.; Shao-Ling, H., et al. Research on the Experimental Conditions and Stability of Protein C Activator Isolated from Snake Venom. J. Mod. Lab. Med. 2004, 19, 12–14. DOI: 10.3969/j.issn.1671-7414.2004.03.005.
   Google Scholar
• Yao, S.; Gen-bao, Z.; Peng-ju, B., et al. Influential Factors on the Experimental Conditions of Amidase Activity of Protein C Activator Isolated from Venom of Agkistrodon Acutus. J Wannan. Med. Univ. 2010, 29, 409–411. DOI: 10.3969/j.issn.1002-0217.2010.06.003.
   Google Scholar
• Çakir, B.; Gülseren, İ.; Mische, S. M. Identification of Novel Proteins from Black Cumin Seed Meals Based on 2D Gel Electrophoresis and MALDI-TOF/TOF-MS Analysis. Plant. Foods. Hum. Nutr. 2019, 74, 414–420. DOI: 10.1007/s11130-019-00751-9.
   PubMed Web of Science ®Google Scholar
• Sauvage, F. L.; Passeron, S.; Marquet, P. Untargeted Screening of Urinary Peptides Using Offline Nano-Liquid Chromatography: MALDI-TOF/TOF Mass Spectrometry. Methods Mol. Biol. 2018, 1788, 113–121. DOI: 10.1007/7651_2017_74.
   PubMedGoogle Scholar
• Ling,Z.; Dong,X.; Feng-Ju, C., et al. Application of Mass Spectrometry Driven BLAST in Protein Identification of Goldfish Embryos.Chinese J Biochem Mol Biol. 2006,22, 672–680. http://cjbmb.bjmu.edu.cn/EN/Y2006/V22/I08/672
   Google Scholar
• Jiaxin, G.; Yujuan, G.; Shuchuan, L., et al. Mechanisms of Acquired Activated Protein C Resistance. J. Clin. Hemat. 2019, 32, 397–399. DOI: 10.13201/j.issn.1004-2806.2019.05.018.
   Google Scholar
• Wu, X.; Dai, J.; Xu, X.; Li, F.; Li, L.; Lu, Y.; Xu, Q.; Ding, Q.; Wu, W.; Wang, X.; et al. Prothrombin Arg541Trp Mutation Leads to Defective PC [Protein C] Pathway Activation and Constitutes a Novel Genetic Risk Factor for Venous Thrombosis. Arterioscler. Thromb. Vasc. Biol. 2020, 40, 483–494. DOI: 10.1161/ATVBAHA.119.313373.
   PubMed Web of Science ®Google Scholar
• Oslakovic, C.; Norstrm, E.; Dahlbck, B. Reevaluation of the Role of HDL in the Anticoagulant Activated Protein C System in Humans. J. Clin. Invest. 2010, 120, 1396–1399. DOI: 10.1172/JCI42260.
   Google Scholar
• Wu, Z. X.; Li, Y. P.; Yao, Y. M. Chin. Crit. Care Med. 2007, 19, 182–185. DOI: 10.3760/j.issn:1003-0603.2007.03.021.
   Google Scholar
• Nakagaki, T.; Latif Kazim, A.; Kisiel . Isolation and Characterization of a Protein C Activator From Tropical Moccasin Venom. Thromb Res. 1990, 58, 593–602. DOI: 10.1016/0049-3848[90]90305-v.
   PubMed Web of Science ®Google Scholar
• Hou, L. Q.; Yu, Q. S.; Guan,J. X. Academic Journal of Guangzhou Medical College.1999,27,79–81.DOI: 10.3969/j.issn.1008-1836.1999.02.031.
   Google Scholar
• Liu, Y.-F.; Hu, J.; Zhang, J.-H.; Wang, S.-L.; Wu, C.-F. Isolation, Purification, and N-terminal Partial Sequence of an Antitumor Peptide from the Venom of the Chinese Scorpion Buthus Martensii Karsch. Prep. Biochem. Biotechnol. 2002, 32, 317–327. DOI: 10.1081/PB-120015456.
   PubMed Web of Science ®Google Scholar